Metástases ósseas

Valente, Maria De Jesus; Paula, Fernanda; Costa, Agostinho; Melo, Maria José

doi:10.1016/S0873-2159(15)31036-9

Article information

Abstract

Download PDF

Statistics

RESUMO

Os autores elaboraram uma revisão teórica sobre metástases ósseas, fouado os seguintes aspectos: incidência e distribuçāo; mecanisnaos e patogénese; diagnóstico, tratamento, avaliação da resposta ao tratamento e prognóstico.

REV PORT PNEUMOL 1998; IV (2): 217-231

Palavras chave:

Metástases ósseas

Cancro

ABSTRACT

The autors have drown up a theoretical review on bone metastases, aiming the following issues: incidence and distribution, mechanisms and pathogenesis, diagnosis, treatment, assessment of response to treatment and prognosis.

REV PORT PNEUMOL 1998; IV (2): 217-231

Key-words:

Bone metastases

Cancer

Full text is only aviable in PDF

BIBIOGRAFIA

[1.]

R.D. Rubens.

Nature of metastatic bone disease.

Metastatic Bone Disease, (1994), pp. 12-19

[2.]

B. Krempien.

Morphological findings in bone metastases, tumorosteopathy and antiosteolytic therapy.

(1994), pp. 59-85

[3.]

L. Hyde, C.L. Hyde.

Clinical manifestations of lung cancer.

Chest., 65 (1974), pp. 299-306

Medline

[4.]

P. Lamy, D. Anthoine, G. Rebeix.

Ostéoses et myéloses cancéreuses d' origine bronchique (Metastatic of bone and bone marrow in bronchogenic carcinoma).

Rev Tuber., 29 (1965), pp. 401

[5.]

A. Clain.

Secondary malignant disease of bone.

Br. J Cancer, 19 (1965), pp. 15

Medline

[6.]

I.J. Diel.

Historial remarks on metastases and metastatic bone disease.

Metastatic Bone Disease, (1994), pp. 1-11

[7.]

[8.]

M.J. Seibel, I. Lambrinoudaki, A. Zipf.

Biochemical markers of bone metabolism in metastatic bone disease, in: Metastatic Bone Disease.

Fundamental and Clinical Aspects., 109–126 (1994),

[9.]

M. Pecherstorfer, I. Zimmer-Roth, T. Schilling, et al.

The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase and urinary ycalcium excretion in neoplastic bone disease.

J Clin Endocrinol Metab., 80 (1995), pp. 97-103

http://dx.doi.org/10.1210/jcem.80.1.7829646 | Medline

[10.]

HERBERT FLEICH, Osteolytic tumor bone disease, in Biphosphonatcs in bone disease. From the laboratory to the patient. Parthenon Publishing. Second Edition. 86-109.

[11.]

L.D. Napoli, H. Hansen, H.H. Muggia.

The incidence of osseous involvement in lung cancer. with special reference to the development of osteoblastic changes.

Radiology., 3 (1973), pp. 165-175

[12.]

H.H. Hansen.

Diagnosis in metastatic sites.

2nd ed., pp. 185-200

[13.]

G.R. Mundy, B.F. Boyce, T. Yoneda.

Mechanisms of osteolytic bone destuction.

Metastatic Bone Disease. Fundamental and Clinical Aspects, (1994), pp. 86-92

[14.]

Serra Maria José.

Terapéutica paliativa e de suporte.

Oncologia Pneumológica, pp. 409-425

[15.]

O.S. Nielsen.

Palliative treatment of bone metastases.

Acta Oncol, 35 (1996), pp. 58-60

Medline

[16.]

S.D. Costa, I.J. Diel, E. Solomayer, G. Von Minc Kwitz, G. Bastert.

Systemic treatment of bone metastases: Review of literature and retrospective analysis of 718 breast cancer patients.

Metastatic Bone Disease, pp. 133-143

[17.]

G. Neumann, H. Gautier, J.R. Maury, P. Malamud, J. Perron.

La prise en charge médicale du malade cancéreux pendant de traitement.

Encyclopedic Méd. Chir. Paris. France, Canccérologie - 50055A50-10, 32 (1983), pp. 22-25

[18.]

H. Fleisch.

Biphosphonates: mechanisms of action and clinical use in hypercalcemia of malignancy and tumor-induced bone destruction.

pp. 144-176

[19.]

A.T. Porter, L.P. Davis.

Systemic radionuclide therapy of bone metastases with strontium-89.

Oncology (Huntingt), 8 (1994 Feb), pp. 93-96

[20.]

E. Ben-Josef, A.T. Porter.

Radioisotopoes in the treatment of bone metastases.

Ann Med, 29 (1997 Feb), pp. 31-35

Medline

[21.]

R.G. Robinson, D.F. Preston, J.A. Spicer, K.G. Baxter.

Radionuclide therapy of intractable bone pain: ennphasis on strontiu-89.

Semin Nucl Med, 22 (1992 Jan), pp. 28-32

Medline

[22.]

J.M. De Klark, B.A. Zonnenberg, G.H. Blijham, A.D. Van Het Schip, A. Hoekstra, S.H. Han, J.M. Quirijnem, Van Dijka, P.P. Van Rjjk.

Treatment of metastatic bone pain using the bone seeking radiopharmaceutical Re-186-HEDP.

Anticancer Re, 17 (1997 May), pp. 1773-1777

[23.]

T. Conroy, L. Malissard, D. Dartois, E. Luporsi, J. Stines, C. Chardot.

Histoire naturelle et evolution des metastases osseuses. A propos de 429 observations.

Bull Cancer, 75 (1988), pp. 845-857

Medline

[24.]

H.D. Covelli, A.J. Zaloznick, K.M. Shekifka.

Evaluation of bone pain in carcinoma of lung.

JAMA., 244 (1980), pp. 2625-2630

Medline

Indexed in:

Follow us:

Indexed in:

Follow us:

Subscribe to our newsletter